Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus.
about
Systematic review of influenza resistance to the neuraminidase inhibitorsPandemic Threat Posed by Avian Influenza A VirusesResistance to anti-influenza drugs: adamantanes and neuraminidase inhibitorsNeuraminidase inhibitors for preventing and treating influenza in children (published trials only)Neuraminidase inhibitors for preventing and treating influenza in childrenNeuraminidase inhibitors for preventing and treating influenza in childrenPerspectives on antiviral use during pandemic influenzaNeuraminidase inhibitors for influenza B virus infection: efficacy and resistanceStructural and Functional Basis of Resistance to Neuraminidase Inhibitors of Influenza B VirusesA Novel I221L Substitution in Neuraminidase Confers High-Level Resistance to Oseltamivir in Influenza B VirusesInfluenza neuraminidase inhibitors: antiviral action and mechanisms of resistanceZanamivir: from drug design to the clinicTreatment of influenza with neuraminidase inhibitors: virological implicationsRWJ-270201 (BCX-1812): a novel neuraminidase inhibitor for influenzaComparison of the activities of zanamivir, oseltamivir, and RWJ-270201 against clinical isolates of influenza virus and neuraminidase inhibitor-resistant variants.Inhibition of neuraminidase inhibitor-resistant influenza virus by DAS181, a novel sialidase fusion proteinHuman-like receptor specificity does not affect the neuraminidase-inhibitor susceptibility of H5N1 influenza virusesImpact of emerging antiviral drug resistance on influenza containment and spread: influence of subclinical infection and strategic use of a stockpile containing one or two drugsIdentification of a PA-binding peptide with inhibitory activity against influenza A and B virus replicationCompetitive Fitness of Influenza B Viruses Possessing E119A and H274Y Neuraminidase Inhibitor Resistance-Associated Substitutions in FerretsEmergence and pandemic potential of swine-origin H1N1 influenza virusUnique Determinants of Neuraminidase Inhibitor Resistance among N3, N7, and N9 Avian Influenza Viruses.Two years after pandemic influenza A/2009/H1N1: what have we learned?Model answers or trivial pursuits? The role of mathematical models in influenza pandemic preparedness planningPandemic influenza and healthcare demand in the Netherlands: scenario analysisNew millennium antivirals against pandemic and epidemic influenza: the neuraminidase inhibitors.Novel strategies for prevention and treatment of influenza.Emergence of drug-resistant influenza virus: population dynamical considerations.Neuraminidase inhibitor-resistant recombinant A/Vietnam/1203/04 (H5N1) influenza viruses retain their replication efficiency and pathogenicity in vitro and in vivo.Zanamivir-resistant influenza viruses with a novel neuraminidase mutationTargeting pandemic influenza: a primer on influenza antivirals and drug resistance.Treatment options for H5N1: lessons learned from the H1N1 pandemic.Neuraminidase inhibitor susceptibility of swine influenza A viruses isolated in Germany between 1981 and 2008.Multidrug-resistant pandemic (H1N1) 2009 infection in immunocompetent childAntiviral strategies for pandemic and seasonal influenzaInfluenza virus resistance to neuraminidase inhibitors: implications for treatment.Update on influenza diagnostics: lessons from the novel H1N1 influenza A pandemicI223R mutation in influenza A(H1N1)pdm09 neuraminidase confers reduced susceptibility to oseltamivir and zanamivir and enhanced resistance with H275YIn vitro selection of influenza B viruses with reduced sensitivity to neuraminidase inhibitorsSusceptibilities of antiviral-resistant influenza viruses to novel neuraminidase inhibitors.
P2860
Q21261835-30A6BEC2-C1D2-487C-B16F-E86081EF7C1BQ22299330-8B6C569A-FE2A-4157-B73D-22B7BADF2847Q22305941-A4CB8519-1F5F-41B2-9E7F-BEC0C234F949Q24200222-E31ED128-3463-4930-94F3-99F586D32110Q24203875-C021C11F-6196-4BA3-9FB7-C2385C8EE233Q24243136-06500B56-9F54-458B-AACE-D03902D2264DQ24522384-0BCBE8BB-ECA6-4C1E-8585-87CF2D2FA25AQ27021579-37513BC2-47BC-4B50-A422-5ABBCEAFC546Q27663966-8007B859-4635-463F-92FD-040F7329BD54Q27683640-C3F95C76-72B5-46DA-826F-50B39A65955CQ28282405-2CA4EE2B-1C2A-487F-B27B-E67E8FF3F39EQ28344586-C5034D9D-FAAF-469E-B035-14A81AC6DCC3Q28344588-021D82AB-D519-457F-8C32-56C4321031B7Q28344592-57722777-DB83-4B0F-B60C-2F4A2D45B21CQ28364114-F277808D-7CF0-41C4-9A4B-FC6923AB410BQ28471835-6E6C1A83-571F-47C9-A0FC-81684A239D3FQ28472513-708287DF-5B72-47D5-AF24-C4ECC6FBF184Q28472846-9E2BB007-4D43-426C-90EC-E46972783298Q28476315-9C9D94AB-AE35-431E-86E3-1502731EE8D4Q28553195-517755F5-E273-41D0-9DAE-FF44C36C4840Q29619003-3F755B98-B5F4-40EB-9CB5-6EB9FEE90346Q30202859-BB88297B-B9B7-43BA-9816-24A2A00717CAQ30224656-D96F5C83-1E41-420D-90D2-313EA158B2B2Q30230076-DABF2806-A1D8-4286-9BB6-92D4BF43152EQ30233416-10942916-E431-4BDB-A9F3-2CC47EF3E626Q30332341-BC9C9EC5-0E60-4723-8C2D-7FD5BFA66CB0Q30350342-68133EC6-1707-4E57-A32D-CD742F338E33Q30353989-4061160E-FEC3-4EE2-B183-3C319B78C8EAQ30364619-5796ADAA-21FA-46A0-8309-FF82161D6616Q30379353-0D5CE25D-F391-433A-9CA7-5603AD189AAAQ30387832-E47E0B2A-03C2-440B-B761-3F249697807CQ30394018-1AB77FEF-9BFA-4F12-8F65-AC511DF35807Q30404038-9D74DFC5-94A9-4617-9BC8-154C53080B4DQ30405407-B3BE240B-96B3-4E1B-B2B8-A22BFAB6BF25Q30408116-47C43EA2-21EB-47C1-B887-A37191F278A2Q30411822-837A23DA-927B-4DAB-AEFB-A578EC90968CQ30415228-A8B2F650-8DE3-4C7D-A2D4-517C6DDAD2B3Q30420810-C3B5373B-59D1-4A40-BAF9-897FC4C18CC3Q30425126-ED40D6C1-7D4F-4231-9C2D-880CCF1B1AABQ30438502-CCDD2F7A-A1B1-479C-9678-72F831461A2F
P2860
Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus.
description
1998 nî lūn-bûn
@nan
1998 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Evidence for zanamivir resista ...... fected with influenza B virus.
@ast
Evidence for zanamivir resista ...... fected with influenza B virus.
@en
type
label
Evidence for zanamivir resista ...... fected with influenza B virus.
@ast
Evidence for zanamivir resista ...... fected with influenza B virus.
@en
prefLabel
Evidence for zanamivir resista ...... fected with influenza B virus.
@ast
Evidence for zanamivir resista ...... fected with influenza B virus.
@en
P2093
P356
P1476
Evidence for zanamivir resista ...... fected with influenza B virus.
@en
P2093
Bethell RC
Brenner MK
Gubareva LV
Matrosovich MN
Webster RG
P304
P356
10.1086/314440
P407
P577
1998-11-01T00:00:00Z